The mission of the MMS Group is the development of a novel brain imaging and physiological monitoring modality by combining near-infrared spectroscopy with magnetic resonance imaging and spectroscopy.
This will enable the fusion of anatomical information and regional measurements of changes in cerebral tissue oxygenation, oxygen utilization and energy metabolism. The instrumentation and techniques we develop can characterize and monitor the progression and treatment of brain injury in human adults, neonates and animals.
Metabolight is the outreach program undertaken by the Multimodal Spectroscopy group. It aims to educate and inform people about the group’s work in using light to better understand the brain.
For more information please visit the website metabolight.org
